Title Information
Title
Improving the Incentives of the FDA Voucher Program for Neglected Tropical Diseases
Name: Personal
Name Part
Arnold, Cameron Graham
Role
Role Term: Text (marcrelator)
author
Name: Personal
Name Part
Pogge, Thomas
Role
Role Term: Text (marcrelator)
author
Type of Resource
text
Genre (aat)
articles
Origin Information
Date Created (encoding="w3cdtf", keyDate="yes")
2015
Language (usage="primary")
Language Term: Code (ISO639-2B)
eng
Physical Description
digitalOrigin
born digital
Extent
pp. 224-235
Related Item: Host
Title Information
Title
Brown Journal of World Affairs
Identifier: ISSN
1080-0786
Part
Part Detail: volume
Part Number
21
Part Caption
no.
Part Detail: issue
Part Number
2
Part Caption
no.
Extent (unit="page")
Start
224
End
235
Abstract (lang="eng")
The article focuses on the aspects of the tropical disease priority review voucher program proposed by the U.S. Food and Drug Administration (FDA), designed to respond on the challenges of developing of drugs following the outbreak of Ebola disease. Topics include the trends on the investment on research and development (R&D) of medicines for neglected tropical diseases (NTDs), the introduction of Orphan Drug Act (ODA), and the criticism on the deficiencies of the program.
Identifier: DOI
10.26300/drpz-6f42